Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human

OA13.06 Autologous Dendritic Cells Loaded with Allogeneic Tumor Cell Lysate (Pheralys ® ) in Patients with Mesothelioma: Final Results of a Phase I Study

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.304 ◽

2017 ◽

Vol 12 (1) ◽

pp. S295 ◽

Cited By ~ 4

Author(s):

Joachim Aerts ◽

Robin Cornelissen ◽

Cor Van Der Leest ◽

Joost Hegmans ◽

Koen Bezemer ◽

...

Keyword(s):

Dendritic Cells ◽

Tumor Cell ◽

Phase I ◽

Phase I Study ◽

Cell Lysate ◽

Allogeneic Tumor ◽

Tumor Cell Lysate ◽

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

Cancer Immunology Immunotherapy ◽

10.1007/s00262-005-0078-6 ◽

2005 ◽

Vol 55 (7) ◽

pp. 819-829 ◽

Cited By ~ 90

Author(s):

Margarita Salcedo ◽

Nadège Bercovici ◽

Rachel Taylor ◽

Pierre Vereecken ◽

Séverine Massicard ◽

...

Keyword(s):

Dendritic Cells ◽

Tumor Cell ◽

Cell Lysate ◽

Allogeneic Tumor ◽

Tumor Cell Lysate ◽

Allogeneic Tumor Cell ◽

Melanoma Patients

Abstract CT229: Autologous dendritic cells loaded with allogeneic tumor cell lysate in patients with mesothelioma: A phase I study

10.1158/1538-7445.am2015-ct229 ◽

2015 ◽

Author(s):

Joachim G. Aerts ◽

Robin Cornelissen ◽

Cor van der Leest ◽

Ferry Eskens ◽

Koen bezemer ◽

...

Keyword(s):

Dendritic Cells ◽

Tumor Cell ◽

Phase I ◽

Phase I Study ◽

Cell Lysate ◽

Allogeneic Tumor ◽

Tumor Cell Lysate ◽

P3.04-27 An Allogeneic Tumor Cell Lysate Vaccine Induces Immune Responses to Lung Cancer Associated Antigens: Preliminary Results of a Phase II Study

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1734 ◽

2018 ◽

Vol 13 (10) ◽

pp. S932

Author(s):

M. Zhang ◽

J. Hong ◽

T. Kunst ◽

C. Bond ◽

J. Yeray ◽

...

Keyword(s):

Lung Cancer ◽

Immune Responses ◽

Tumor Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Preliminary Results ◽

Cell Lysate ◽

Allogeneic Tumor ◽

Tumor Cell Lysate ◽

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

Translational Lung Cancer Research ◽

10.21037/tlcr.2019.05.05 ◽

2019 ◽

Vol 8 (3) ◽

pp. 280-285 ◽

Cited By ~ 9

Author(s):

Robert A. Belderbos ◽

◽

Paul Baas ◽

Rossana Berardi ◽

Robin Cornelissen ◽

...

Keyword(s):

Dendritic Cells ◽

Dendritic Cell ◽

Maintenance Therapy ◽

Tumor Cell ◽

Phase Ii ◽

Cell Lysate ◽

Randomized Phase Ii ◽

Cell Immunotherapy ◽

Tumor Cell Lysate ◽

Clinical and Immunological Effects in Patients with Advanced Non-Small Cell Lung-Cancer after Vaccination with Dendritic Cells Exposed to an Allogeneic Tumor Cell Lysate

World Journal of Vaccines ◽

10.4236/wjv.2013.32011 ◽

2013 ◽

Vol 03 (02) ◽

pp. 68-76 ◽

Author(s):

Lotte Engell-Noerregaard ◽

Pia Kvistborg ◽

Mai-Britt Zocca ◽

Ayako W. Pedersen ◽

Mogens H. Claesson ◽

...

Keyword(s):

Lung Cancer ◽

Dendritic Cells ◽

Tumor Cell ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lysate ◽

Immunological Effects ◽

Tumor Cell Lysate ◽

Effect of Dendritic Cell Based Cancer Vaccine Using Allogeneic Tumor Cell Lysate in Melanoma Pulmonary Metastasis Model

Immune Network ◽

10.4110/in.2005.5.3.163 ◽

2005 ◽

Vol 5 (3) ◽

pp. 163 ◽

Author(s):

Young-Joon Lee ◽

Myung Joo Kim ◽

So Hee In ◽

Ok-Mi Choi ◽

Soyoung Baek ◽

...

Keyword(s):

Dendritic Cell ◽

Tumor Cell ◽

Cancer Vaccine ◽

Pulmonary Metastasis ◽

Cell Lysate ◽

Allogeneic Tumor ◽

Metastasis Model ◽

Tumor Cell Lysate ◽

Phase II Evaluation of an Allogeneic Tumor Cell Lysate Vaccine with or without Metronomic Oral Cyclophosphamide and Celecoxib in Patients with Thoracic Malignancies

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2017.07.547 ◽

2017 ◽

Vol 225 (4) ◽

pp. e10

Author(s):

David S. Schrump ◽

Mary Zhang ◽

Julie Hong ◽

Javier Yeray ◽

Min-Jung Lee ◽

...

Keyword(s):

Tumor Cell ◽

Phase Ii ◽

Oral Cyclophosphamide ◽

Cell Lysate ◽

Allogeneic Tumor ◽

Tumor Cell Lysate ◽

Allogeneic Tumor Cell ◽

Thoracic Malignancies

Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407–426 and OK-432

International Immunopharmacology ◽

10.1016/j.intimp.2011.10.001 ◽

2011 ◽

Vol 11 (12) ◽

pp. 2200-2207 ◽

Author(s):

Chiyu Ge ◽

Yun Xing ◽

Qi Wang ◽

Wen Xiao ◽

Yong Lu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Dendritic Cells ◽

Tumor Cell ◽

Tandem Repeats ◽

Therapeutic Vaccination ◽

Peptide Epitope ◽

Cell Lysate ◽

Tumor Cell Lysate

Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect ofIFN-? gene therapy for malignant glioma in an experimental mouse intracranial glioma

International Journal of Cancer ◽

10.1002/ijc.20331 ◽

2004 ◽

Vol 111 (5) ◽

pp. 777-782 ◽

Cited By ~ 23

Author(s):

Ryuta Saito ◽

Masaaki Mizuno ◽

Norimoto Nakahara ◽

Takaya Tsuno ◽

Toshihiro Kumabe ◽

...

Keyword(s):

Gene Therapy ◽

Dendritic Cells ◽

Tumor Cell ◽

Malignant Glioma ◽

Cell Lysate ◽

Tumor Cell Lysate ◽

Experimental Mouse